Top

Published in:

01-02-2013 | Palliative Care

Palliative Venting Gastrostomy in Patients with Malignant Bowel Obstruction and Ascites

Authors: Colette Shaw, MD, Roland L. Bassett, MS, Patricia S. Fox, MS, Kathleen M. Schmeler, MD, Michael J. Overman, MD, Michael J. Wallace, MD, Sanjay Gupta, MD, Alda Tam, MD

Published in: Annals of Surgical Oncology | Issue 2/2013

Abstract

Background

Fluoroscopic-guided placement of a percutaneous decompression gastrostomy tube (PDGT) is used to palliate patients with malignant bowel obstruction (MBO). We report our clinical experience in cases of MBO and ascites that were known to be technically difficult and at increased risk for complications after PDGT placement.

Methods

Between October 2005 and April 2010, a total of 89 consecutive oncology patients with MBO and ascites underwent at least one attempt at PDGT placement. We retrospectively reviewed the electronic medical record to collect demographic details, procedure information, and morbidity and mortality data. Kaplan–Meier curves were used to calculate median survival after PDGT.

Results

Ninety-three new gastrostomy encounters occurred in 89 patients. The primary and secondary technical success rates were 72 % (67 of 93) and 77.4 % (72 of 93), respectively. Inadequate gastric distention was the reason for failure in 84.6 % (22 of 26) of the cases in which the initial PDGT attempt was unsuccessful. For ascites management, 13 patients underwent paracentesis and 78 patients underwent placement of an intraperitoneal catheter. The overall complication rate in successful placements was 13.9 %, with a major complication rate of 9.7 %. After PDGT, the median overall survival rate was 28.5 days (95 % confidence interval 20–42).

Conclusions

PDGT is feasible in the majority of patients with MBO and ascites, although there is an inherent risk of major complications. An intraperitoneal catheter can be used to manage ascites to facilitate PDGT.

Solomon HJ, Atkinson KH, Coppleson JV, et al. Bowel complications in the management of ovarian cancer. Aust N Z J Obstet Gynaecol. 1983;23:65–8.PubMedCrossRef

Tunca JC, Buchler DA, Mack EA, et al. The management of ovarian-cancer-caused bowel obstruction. Gynecol Oncol. 1981;12:186–92.PubMedCrossRef

Baines M, Oliver DJ, Carter RL. Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet. 1985;2:990–3.

Lund B, Hansen M, Lundvall F, et al. Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy. Surg Gynecol Obstet. 1989;169:213–8.PubMed

Phillips RK, Hittinger R, Fry JS, Fielding LP. Malignant large bowel obstruction. Br J Surg. 1985;72:296–302.PubMedCrossRef

Krebs HB, Goplerud DR. Mechanical intestinal obstruction in patients with gynecologic disease: a review of 368 patients. Am J Obstet Gynecol. 1987;157:577–83.PubMed

Rubin SC, Hoskins WJ, Benjamin I, Lewis JL Jr. Palliative surgery for intestinal obstruction in advanced ovarian cancer. Gynecol Oncol. 1989;34:16–9.PubMedCrossRef

Krebs HB, Goplerud DR. Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol. 1983;61:327–30.PubMed

Gemlo B, Rayner AA, Lewis B, et al. Home support of patients with end-stage malignant bowel obstruction using hydration and venting gastrostomy. Am J Surg. 1986;152:100–4.PubMedCrossRef

10.

van Ooijen B, van der Burg ME, Planting AS, et al. Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin. Surg Gynecol Obstet. 1993;176:469–74.PubMed

11.

Abuksis G, Mor M, Segal N, et al. Percutaneous endoscopic gastrostomy: high mortality rates in hospitalized patients. Am J Gastroenterol. 2000;95:128–32.PubMedCrossRef

12.

Ripamonti C. Management of bowel obstruction in advanced cancer. Curr Opin Oncol. 1994;6:351–7.PubMedCrossRef

13.

Addison NV. Pseudo-obstruction of the large bowel. J R Soc Med. 1983;76:252–5.PubMed

14.

Lautenbach E, Lichtenstein GR. Retroperitoneal leiomyosarcoma and gastroparesis: a new association and review of tumor-associated intestinal pseudo-obstruction. Am J Gastroenterol. 1995;90:1338–41.PubMed

15.

Liang BC, Albers JW, Sima AA, Nostrant TT. Paraneoplastic pseudo-obstruction, mononeuropathy multiplex, and sensory neuronopathy. Muscle Nerve. 1994;17:91–6.PubMedCrossRef

16.

Spears H, Petrelli NJ, Herrera L, Mittelman A. Treatment of bowel obstruction after operation for colorectal carcinoma. Am J Surg. 1988;155:383–6.PubMedCrossRef

17.

Mangili G, Aletti G, Frigerio L, et al. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis. Int J Gynecol Cancer. 2005;15:830–5.PubMedCrossRef

18.

Wills JS, Oglesby JT. Percutaneous gastrostomy. Radiology. 1983;149:449–53.PubMed

19.

Ho CS, Gray RR, Goldfinger M, et al. Percutaneous gastrostomy for enteral feeding. Radiology. 1985;156:349–51.PubMed

20.

Nicholson FB, Korman MG, Richardson MA. Percutaneous endoscopic gastrostomy: a review of indications, complications and outcome. J Gastroenterol Hepatol. 2000;15:21–5.PubMedCrossRef

21.

McFarland EG, Lee MJ, Boland GW, Mueller PR. Gastropexy breakdown and peritonitis after percutaneous gastrojejunostomy in a patient with ascites. AJR Am J Roentgenol. 1995;164:189–93.PubMed

22.

O’Keeffe F, Carrasco CH, Charnsangavej C, et al. Percutaneous drainage and feeding gastrostomies in 100 patients. Radiology. 1989;172:341–3.PubMed

23.

Ryan JM, Hahn PF, Mueller PR. Performing radiologic gastrostomy or gastrojejunostomy in patients with malignant ascites. AJR Am J Roentgenol. 1998;171:1003–6.PubMed

24.

Garrison RN, Kaelin LD, Galloway RH, Heuser LS. Malignant ascites. Clinical and experimental observations. Ann Surg. 1986;203:644–51.PubMedCrossRef

25.

Malden LT, Tattersall MH. Malignant effusions. Q J Med. 1986;58:221–39.PubMed

26.

Cardozo P. A critical evaluation of 3000 cytologic analyses of pleural fluid, ascitic fluid, and pericardial fluid. Acta Cytol. 1966;10:455.

27.

Zera RT, Nava HR, Fischer JI. Percutaneous endoscopic gastrostomy (PEG) in cancer patients. Surg Endosc. 1993;7:304–7.PubMedCrossRef

28.

Wollman B, D’Agostino HB, Walus-Wigle JR, et al. Radiologic, endoscopic, and surgical gastrostomy: an institutional evaluation and meta-analysis of the literature. Radiology. 1995;197:699–704.PubMed

29.

Bell SD, Carmody EA, Yeung EY, et al. Percutaneous gastrostomy and gastrojejunostomy: additional experience in 519 procedures. Radiology. 1995;194:817–20.PubMed

30.

Wallace MJ, Chin KW, Fletcher TB, et al. Quality improvement guidelines for percutaneous drainage/aspiration of abscess and fluid collections. J Vasc Interv Radiol. 2010;21:431–5.PubMedCrossRef

31.

U.S. Department of Health and Human Services NIoH, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). http://evs.nci.nih.gov/ftp1/CTCAE. Version 4.03 (June 2010).

32.

Mercadante S, Casuccio A, Mangione S. Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage. 2007;33:217–23.PubMedCrossRef

33.

Cunningham MJ, Bromberg C, Kredentser DC, et al. Percutaneous gastrostomy for decompression in patients with advanced gynecologic malignancies. Gynecol Oncol. 1995;59:273–6.PubMedCrossRef

34.

Pothuri B, Montemarano M, Gerardi M, et al. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol. 2005;96:330–4.PubMedCrossRef

35.

Brooksbank MA, Game PA, Ashby MA. Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med. 2002;16:520–6.PubMedCrossRef

36.

Campagnutta E, Cannizzaro R, Gallo A, et al. Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy. Gynecol Oncol. 1996;62:103–5.PubMedCrossRef

37.

Laval G, Arvieux C, Stefani L, et al. Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage. 2006;31:502–12.PubMedCrossRef

38.

Herman LL, Hoskins WJ, Shike M. Percutaneous endoscopic gastrostomy for decompression of the stomach and small bowel. Gastrointest Endosc. 1992;38:314–8.PubMedCrossRef

39.

Ripamonti C, Twycross R, Baines M, et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer. 2001;9:223–33.PubMedCrossRef

40.

Lee MJ, Saini S, Brink JA, et al. Malignant small bowel obstruction and ascites: not a contraindication to percutaneous gastrostomy. Clin Radiol. 1991;44:332–4.PubMedCrossRef

41.

Marks WH, Perkal MF, Schwartz PE. Percutaneous endoscopic gastrostomy for gastric decompression in metastatic gynecologic malignancies. Surg Gynecol Obstet. 1993;177:573–6.PubMed

Title: Palliative Venting Gastrostomy in Patients with Malignant Bowel Obstruction and Ascites
Authors: Colette Shaw, MD
Roland L. Bassett, MS
Patricia S. Fox, MS
Kathleen M. Schmeler, MD
Michael J. Overman, MD
Michael J. Wallace, MD
Sanjay Gupta, MD
Alda Tam, MD
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 2/2013
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-012-2643-5

At a glance: The STEP trials

Springer Medicine

Palliative Venting Gastrostomy in Patients with Malignant Bowel Obstruction and Ascites

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2013

The Increasing Credibility of Sentinel Lymph Node Mapping in Endometrial Cancer

Gastrointestinal Stromal Tumor of the Rectum: Results of Surgical and Multimodality Therapy in the Era of Imatinib

Detection of Recurrences During Follow-up After Liver Surgery for Colorectal Metastases: Both Carcinoembryonic Antigen (CEA) and Imaging are Important

Racial Disparities in Immediate Breast Reconstruction After Mastectomy: Impact of State and Federal Health Policy Changes

Phase II Trial of Adjuvant Chemotherapy with S-1 for Colorectal Liver Metastasis

Quality of Care Indicators for the Surgical Treatment of Gastric Cancer: A Systematic Review